LG Chem partners with UK's LabGenius on AI cancer drugs
LG Chem signed a joint research and license option agreement with UK-based LabGenius to develop AI-powered multispecific antibody therapies for cancer. The collaboration uses LabGenius's EVA platform to accelerate antibo…